Investor Relations


SciClone Pharmaceuticals (NASDAQ: SCLN) is a revenue-generating, China-centric, specialty pharmaceutical company with a substantial international business and a product portfolio of novel therapies for cancer and infectious diseases. The Company is focused on continuing sales growth and

... More »

pdf China Regulatory and Commercialization Backgrounder

Recent Releases

May 16, 2013
SciClone Reports Anticipated Financial Results for the First Quarter 2013

May 16, 2013
SciClone and Zensun Enter Into a Licensing Agreement for Novel Chronic Heart Failure Drug Neucardin(TM) for the China Market

View all releases »

Events & Presentations

Jun 5, 2013 at 12:30 PM ET
Jefferies 2013 Global Healthcare Conference

Apr 1, 2013 at 4:30 PM ET
Q4 2012 SciClone Pharmaceuticals, Inc. Earnings

View all events & presentations »

Stock Chart
Stock price graph
3 Mo.   6 Mo.   1 Yr.
Stock Quote
SciClone Pharmaceuticals, Inc.
Price: 4.86
Change: - 0.11
Day High: 4.93
Day Low: 4.78
Volume: 103,400
Delayed at least 20 minutes.
Provided by eSignal.